Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer

Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors

NCT01988896 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

NCT07196644 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06031441 ·Status: RECRUITING ·Phase: PHASE1

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

NCT03744468 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT02410512 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)

NCT03399643 ·Status: TERMINATED

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

NCT05765851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT06488716 ·Status: TERMINATED ·Phase: PHASE1

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

NCT04214093 ·Status: TERMINATED ·Phase: PHASE1

A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors

NCT03995472 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

NCT05494762 ·Status: TERMINATED ·Phase: PHASE1

Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors

NCT04678921 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors

NCT02794571 ·Status: COMPLETED ·Phase: PHASE1

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

NCT05898399 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT04250155 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

NCT02304393 ·Status: COMPLETED ·Phase: PHASE1

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

NCT03915678 ·Status: RECRUITING ·Phase: PHASE2

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

NCT03768063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors

NCT05389462 ·Status: TERMINATED ·Phase: PHASE1

Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05474859 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours

NCT05537051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

NCT02715531 ·Status: COMPLETED ·Phase: PHASE1

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

NCT04986865 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

NCT00878423 ·Status: COMPLETED ·Phase: PHASE1